India — Whole Grains, Milled Grain Products, and Starch — Rice

Higher risk. India ranks 2nd of 7 origins shipping rice to the US on border rejections per $1 billion of US imports, at 89.3 — above 83% of them.

least riskmost risk

← back to leaderboard

India received 226 FDA import refusals in Rice, part of Whole Grains, Milled Grain Products, and Starch between 2023-Q4 and 2026-Q3. Volume peaked at 40 in 2024-Q1, with the trend falling sharply year-on-year. The most-cited issues are pesticide, salmonella, and poisonous. Measured against US import value, that runs at 89.3 notifications per $1 billion of imports of this commodity from India over the last 3 years.

Of these, 225 were hazard refusals and 1 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

33 2023-Q4 2023-Q4: 33 40 2024-Q1 2024-Q1: 40 19 2024-Q2 2024-Q2: 19 31 2024-Q3 2024-Q3: 31 22 2024-Q4 2024-Q4: 22 24 2025-Q1 2025-Q1: 24 9 2025-Q2 2025-Q2: 9 23 2025-Q3 2025-Q3: 23 7 2025-Q4 2025-Q4: 7 6 2026-Q1 2026-Q1: 6 6 2026-Q2 2026-Q2: 6 6 2026-Q3 2026-Q3: 6

Recent rejections